REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dybimagen S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dybimagen S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Dybimagen S.A. is based in Ecuador. The head office is in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on July 23, 1998. It currently has a total number of 18 (2023) employees. From the latest financial highlights, Dybimagen S.A. reported a net sales revenue drop of 13.18% in 2023. There was a total negative growth of 15.74% in Dybimagen S.A.’s total assets over the same period. The enterprise’s net profit margin decreased by 2.15% in 2023.

Headquarters
Luis Banderas N52-131, Romero Correa Bldg.
Quito; Pichincha;

Contact Details: Purchase the Dybimagen S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Dybimagen S.A. report to view the information.
Outstanding Shares:
Purchase the Dybimagen S.A. report to view the information.
Registered Capital:
Purchase the Dybimagen S.A. report to view the information.
Incorporation Date:
July 23, 1998
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Holding Tonicorp S.A.
0.01%
Company Performance
Financial values in the chart are available after Dybimagen S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-13.18%▼
Total operating revenue
-13.62%▼
Operating profit (EBIT)
-75.87%▼
EBITDA
-69.23%▼
Net Profit (Loss) for the Period
-31.58%▼
Total assets
-15.74%▼
Total equity
-15.48%▼
Operating Profit Margin (ROS)
-33.56%▼
Net Profit Margin
-2.15%▼
Return on Equity (ROE)
-0.89%▼
Debt to Equity Ratio
-0.06%▼
Quick Ratio
0.59%▲
Cash Ratio
0.67%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo